Literature DB >> 8770464

A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.

A Kannio1, M Ridanpää, H Koskinen, T Partanen, S Anttila, Y Collan, E Hietanen, H Vainio, K Husgafvel-Pursiainen.   

Abstract

In this study, we found an unexpected association (crude odds ratio = 2.8; 95% confidence interval = 0.9-8.4) between definite work-related exposure to asbestos and carcinoma of the urinary bladder in a small group of patients (n = 28) initially recruited as referents for an epidemiological feasibility study on the occupational causes of lung cancer. We extended the study by using molecular methods to examine mutations in the p53 tumor suppressor gene in the same cases of bladder cancers. The same number of archival samples of transitional cell carcinoma, mainly of grade 3, were added to the analysis. We failed to show any association between occupational exposure to asbestos and p53 mutations among bladder cancer patients. We observed an increasing occurrence of p53 mutations in nonsmokers (5 of 17, 29%), former smokers (8 of 21, 38%), and current smokers (9 of 16, 56%) in that order; however, this was not statistically significant. The most prevalent type of mutation was G:C to A:T transition. Tumor grade was not associated with the frequency of mutations, but the higher stage (T3-T4) tumors appeared to have mutations more frequently than did the less invasive tumors (T1-T2).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770464

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Overcoming cellular senescence in human cancer pathogenesis.

Authors:  T R Yeager; S DeVries; D F Jarrard; C Kao; S Y Nakada; T D Moon; R Bruskewitz; W M Stadler; L F Meisner; K W Gilchrist; M A Newton; F M Waldman; C A Reznikoff
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

2.  LKB1 somatic mutations in sporadic tumors.

Authors:  E Avizienyte; A Loukola; S Roth; A Hemminki; M Tarkkanen; R Salovaara; J Arola; R Bützow; K Husgafvel-Pursiainen; A Kokkola; H Järvinen; L A Aaltonen
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

3.  Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.

Authors:  Weimin Gao; Marjorie Romkes; Shilong Zhong; Tomoko Nukui; Raj A Persad; Patrick J B Smith; Robert Branch; Phouthone Keohavong
Journal:  Oncol Rep       Date:  2010-07       Impact factor: 3.906

4.  The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability.

Authors:  Michael Overholtzer; Pulivarthi H Rao; Reyna Favis; Xin-Yan Lu; Michael B Elowitz; Francis Barany; Marc Ladanyi; Richard Gorlick; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

5.  Cigarette smoking and p53 mutations in lung cancer and bladder cancer.

Authors:  K Husgafvel-Pursiainen; A Kannio
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.